nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—CPT1A—breast cancer	0.26	0.651	CbGaD
L-Carnitine—SLCO1B1—breast cancer	0.139	0.349	CbGaD
L-Carnitine—SLC22A16—Doxorubicin—breast cancer	0.0944	0.289	CbGbCtD
L-Carnitine—CES1—Capecitabine—breast cancer	0.0558	0.171	CbGbCtD
L-Carnitine—CES1—Tamoxifen—breast cancer	0.0449	0.137	CbGbCtD
L-Carnitine—CES1—Irinotecan—breast cancer	0.0345	0.106	CbGbCtD
L-Carnitine—MPO—Carboplatin—breast cancer	0.0284	0.0871	CbGbCtD
L-Carnitine—XDH—Carboplatin—breast cancer	0.0284	0.0871	CbGbCtD
L-Carnitine—XDH—Doxorubicin—breast cancer	0.0163	0.0498	CbGbCtD
L-Carnitine—SLCO1B1—Irinotecan—breast cancer	0.0118	0.0363	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—breast cancer	0.00627	0.0192	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—breast cancer	0.00579	0.0177	CbGbCtD
L-Carnitine—CROT—mammary gland—breast cancer	0.00212	0.0338	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—breast cancer	0.00208	1	CbGdCrCtD
L-Carnitine—SLC25A20—nipple—breast cancer	0.00152	0.0243	CbGeAlD
L-Carnitine—CRAT—nipple—breast cancer	0.00148	0.0236	CbGeAlD
L-Carnitine—SLC22A16—female reproductive system—breast cancer	0.00121	0.0193	CbGeAlD
L-Carnitine—SLC25A29—endometrium—breast cancer	0.00115	0.0184	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—breast cancer	0.00114	0.0183	CbGeAlD
L-Carnitine—CPT2—nipple—breast cancer	0.00114	0.0182	CbGeAlD
L-Carnitine—CROT—skin of body—breast cancer	0.00112	0.0179	CbGeAlD
L-Carnitine—SLC25A29—pituitary gland—breast cancer	0.00104	0.0167	CbGeAlD
L-Carnitine—SLC25A29—adipose tissue—breast cancer	0.00104	0.0166	CbGeAlD
L-Carnitine—SLC22A16—endocrine gland—breast cancer	0.00102	0.0164	CbGeAlD
L-Carnitine—SLC25A20—skin of body—breast cancer	0.000975	0.0156	CbGeAlD
L-Carnitine—CROT—uterus—breast cancer	0.000974	0.0156	CbGeAlD
L-Carnitine—CROT—pituitary gland—breast cancer	0.000956	0.0153	CbGeAlD
L-Carnitine—SLC25A29—female reproductive system—breast cancer	0.000955	0.0152	CbGeAlD
L-Carnitine—CROT—adipose tissue—breast cancer	0.000952	0.0152	CbGeAlD
L-Carnitine—CRAT—skin of body—breast cancer	0.000946	0.0151	CbGeAlD
L-Carnitine—SLC25A29—adrenal gland—breast cancer	0.000932	0.0149	CbGeAlD
L-Carnitine—SLC25A20—endometrium—breast cancer	0.000919	0.0147	CbGeAlD
L-Carnitine—CRAT—endometrium—breast cancer	0.000892	0.0142	CbGeAlD
L-Carnitine—CROT—female reproductive system—breast cancer	0.000876	0.014	CbGeAlD
L-Carnitine—SLC25A29—female gonad—breast cancer	0.000869	0.0139	CbGeAlD
L-Carnitine—CROT—adrenal gland—breast cancer	0.000854	0.0136	CbGeAlD
L-Carnitine—SLC25A20—uterus—breast cancer	0.000847	0.0135	CbGeAlD
L-Carnitine—SLC25A20—pituitary gland—breast cancer	0.000832	0.0133	CbGeAlD
L-Carnitine—SLC25A20—adipose tissue—breast cancer	0.000829	0.0132	CbGeAlD
L-Carnitine—CROT—bone marrow—breast cancer	0.000827	0.0132	CbGeAlD
L-Carnitine—CRAT—uterus—breast cancer	0.000822	0.0131	CbGeAlD
L-Carnitine—SLC25A29—endocrine gland—breast cancer	0.000808	0.0129	CbGeAlD
L-Carnitine—CRAT—pituitary gland—breast cancer	0.000807	0.0129	CbGeAlD
L-Carnitine—CRAT—adipose tissue—breast cancer	0.000804	0.0128	CbGeAlD
L-Carnitine—CROT—female gonad—breast cancer	0.000797	0.0127	CbGeAlD
L-Carnitine—SLC25A20—female reproductive system—breast cancer	0.000762	0.0122	CbGeAlD
L-Carnitine—Choline—PDE4D—breast cancer	0.000744	0.448	CrCbGaD
L-Carnitine—SLC25A20—adrenal gland—breast cancer	0.000743	0.0119	CbGeAlD
L-Carnitine—CROT—endocrine gland—breast cancer	0.000741	0.0118	CbGeAlD
L-Carnitine—CRAT—female reproductive system—breast cancer	0.000739	0.0118	CbGeAlD
L-Carnitine—CPT2—skin of body—breast cancer	0.000728	0.0116	CbGeAlD
L-Carnitine—CRAT—adrenal gland—breast cancer	0.000721	0.0115	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—breast cancer	0.000719	0.0115	CbGeAlD
L-Carnitine—SLCO1B1—mammary gland—breast cancer	0.000701	0.0112	CbGeAlD
L-Carnitine—CRAT—bone marrow—breast cancer	0.000698	0.0111	CbGeAlD
L-Carnitine—SLC25A20—female gonad—breast cancer	0.000693	0.0111	CbGeAlD
L-Carnitine—CPT2—endometrium—breast cancer	0.000686	0.011	CbGeAlD
L-Carnitine—CRAT—female gonad—breast cancer	0.000672	0.0107	CbGeAlD
L-Carnitine—CPT1A—adipose tissue—breast cancer	0.000652	0.0104	CbGeAlD
L-Carnitine—SLC25A20—endocrine gland—breast cancer	0.000645	0.0103	CbGeAlD
L-Carnitine—CPT2—uterus—breast cancer	0.000632	0.0101	CbGeAlD
L-Carnitine—CRAT—endocrine gland—breast cancer	0.000625	0.00999	CbGeAlD
L-Carnitine—SLC22A4—mammary gland—breast cancer	0.000622	0.00994	CbGeAlD
L-Carnitine—CPT2—pituitary gland—breast cancer	0.000621	0.00992	CbGeAlD
L-Carnitine—CPT2—adipose tissue—breast cancer	0.000618	0.00988	CbGeAlD
L-Carnitine—CPT1A—female reproductive system—breast cancer	0.000599	0.00957	CbGeAlD
L-Carnitine—CPT1A—adrenal gland—breast cancer	0.000584	0.00934	CbGeAlD
L-Carnitine—Choline—ACHE—breast cancer	0.000577	0.347	CrCbGaD
L-Carnitine—CPT2—female reproductive system—breast cancer	0.000568	0.00908	CbGeAlD
L-Carnitine—SLC25A29—lymph node—breast cancer	0.000558	0.00892	CbGeAlD
L-Carnitine—CPT2—adrenal gland—breast cancer	0.000555	0.00886	CbGeAlD
L-Carnitine—CPT1A—female gonad—breast cancer	0.000545	0.00871	CbGeAlD
L-Carnitine—CPT2—bone marrow—breast cancer	0.000537	0.00857	CbGeAlD
L-Carnitine—XDH—endometrium—breast cancer	0.000534	0.00854	CbGeAlD
L-Carnitine—CPT2—female gonad—breast cancer	0.000517	0.00826	CbGeAlD
L-Carnitine—CROT—lymph node—breast cancer	0.000512	0.00818	CbGeAlD
L-Carnitine—CPT1A—endocrine gland—breast cancer	0.000507	0.0081	CbGeAlD
L-Carnitine—CPT2—endocrine gland—breast cancer	0.000481	0.00768	CbGeAlD
L-Carnitine—SLC25A20—lymph node—breast cancer	0.000446	0.00712	CbGeAlD
L-Carnitine—XDH—female reproductive system—breast cancer	0.000443	0.00707	CbGeAlD
L-Carnitine—CRAT—lymph node—breast cancer	0.000432	0.00691	CbGeAlD
L-Carnitine—SLC22A5—mammary gland—breast cancer	0.000412	0.00658	CbGeAlD
L-Carnitine—MPO—epithelium—breast cancer	0.000379	0.00606	CbGeAlD
L-Carnitine—XDH—endocrine gland—breast cancer	0.000375	0.00598	CbGeAlD
L-Carnitine—CES1—adipose tissue—breast cancer	0.000367	0.00587	CbGeAlD
L-Carnitine—MPO—skin of body—breast cancer	0.000361	0.00577	CbGeAlD
L-Carnitine—CPT1A—lymph node—breast cancer	0.00035	0.0056	CbGeAlD
L-Carnitine—SLC22A5—nipple—breast cancer	0.000341	0.00544	CbGeAlD
L-Carnitine—Choline—BCHE—breast cancer	0.000339	0.204	CrCbGaD
L-Carnitine—CES1—female reproductive system—breast cancer	0.000338	0.00539	CbGeAlD
L-Carnitine—CPT2—lymph node—breast cancer	0.000333	0.00531	CbGeAlD
L-Carnitine—CES1—adrenal gland—breast cancer	0.000329	0.00526	CbGeAlD
L-Carnitine—SLC22A4—endometrium—breast cancer	0.000311	0.00496	CbGeAlD
L-Carnitine—MPO—pituitary gland—breast cancer	0.000308	0.00492	CbGeAlD
L-Carnitine—CES1—female gonad—breast cancer	0.000307	0.00491	CbGeAlD
L-Carnitine—SLCO1B1—female reproductive system—breast cancer	0.00029	0.00463	CbGeAlD
L-Carnitine—CES1—endocrine gland—breast cancer	0.000286	0.00456	CbGeAlD
L-Carnitine—SLC22A4—pituitary gland—breast cancer	0.000281	0.00449	CbGeAlD
L-Carnitine—SLC22A4—adipose tissue—breast cancer	0.00028	0.00447	CbGeAlD
L-Carnitine—MPO—adrenal gland—breast cancer	0.000275	0.00439	CbGeAlD
L-Carnitine—MPO—bone marrow—breast cancer	0.000266	0.00425	CbGeAlD
L-Carnitine—SLC22A4—female reproductive system—breast cancer	0.000257	0.00411	CbGeAlD
L-Carnitine—SLC22A4—adrenal gland—breast cancer	0.000251	0.00401	CbGeAlD
L-Carnitine—SLCO1B1—endocrine gland—breast cancer	0.000245	0.00392	CbGeAlD
L-Carnitine—SLC22A4—bone marrow—breast cancer	0.000243	0.00388	CbGeAlD
L-Carnitine—MPO—endocrine gland—breast cancer	0.000239	0.00381	CbGeAlD
L-Carnitine—SLC22A5—skin of body—breast cancer	0.000218	0.00348	CbGeAlD
L-Carnitine—SLC22A5—endometrium—breast cancer	0.000206	0.00328	CbGeAlD
L-Carnitine—CES1—lymph node—breast cancer	0.000197	0.00315	CbGeAlD
L-Carnitine—SLC22A5—pituitary gland—breast cancer	0.000186	0.00297	CbGeAlD
L-Carnitine—SLC22A5—adipose tissue—breast cancer	0.000185	0.00296	CbGeAlD
L-Carnitine—SLC22A5—female reproductive system—breast cancer	0.00017	0.00272	CbGeAlD
L-Carnitine—SLC22A5—adrenal gland—breast cancer	0.000166	0.00266	CbGeAlD
L-Carnitine—MPO—lymph node—breast cancer	0.000165	0.00263	CbGeAlD
L-Carnitine—SLC22A5—female gonad—breast cancer	0.000155	0.00248	CbGeAlD
L-Carnitine—SLC22A4—lymph node—breast cancer	0.000151	0.00241	CbGeAlD
L-Carnitine—SLC22A5—lymph node—breast cancer	9.96e-05	0.00159	CbGeAlD
L-Carnitine—Headache—Thiotepa—breast cancer	4.8e-05	0.000427	CcSEcCtD
L-Carnitine—Palpitations—Capecitabine—breast cancer	4.79e-05	0.000426	CcSEcCtD
L-Carnitine—Chest pain—Docetaxel—breast cancer	4.77e-05	0.000424	CcSEcCtD
L-Carnitine—Myalgia—Docetaxel—breast cancer	4.77e-05	0.000424	CcSEcCtD
L-Carnitine—Nausea—Vinorelbine—breast cancer	4.76e-05	0.000424	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—breast cancer	4.75e-05	0.000423	CcSEcCtD
L-Carnitine—Dyspepsia—Paclitaxel—breast cancer	4.75e-05	0.000422	CcSEcCtD
L-Carnitine—Asthenia—Irinotecan—breast cancer	4.74e-05	0.000422	CcSEcCtD
L-Carnitine—Asthenia—Mitoxantrone—breast cancer	4.74e-05	0.000422	CcSEcCtD
L-Carnitine—Cough—Capecitabine—breast cancer	4.73e-05	0.000421	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—breast cancer	4.7e-05	0.000418	CcSEcCtD
L-Carnitine—Decreased appetite—Paclitaxel—breast cancer	4.69e-05	0.000417	CcSEcCtD
L-Carnitine—Hypertension—Capecitabine—breast cancer	4.68e-05	0.000417	CcSEcCtD
L-Carnitine—Hypersensitivity—Fluorouracil—breast cancer	4.66e-05	0.000415	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—breast cancer	4.66e-05	0.000415	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Paclitaxel—breast cancer	4.65e-05	0.000414	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—breast cancer	4.64e-05	0.000413	CcSEcCtD
L-Carnitine—Asthenia—Gemcitabine—breast cancer	4.62e-05	0.000411	CcSEcCtD
L-Carnitine—Chest pain—Capecitabine—breast cancer	4.62e-05	0.000411	CcSEcCtD
L-Carnitine—Myalgia—Capecitabine—breast cancer	4.62e-05	0.000411	CcSEcCtD
L-Carnitine—Pain—Paclitaxel—breast cancer	4.61e-05	0.00041	CcSEcCtD
L-Carnitine—Constipation—Paclitaxel—breast cancer	4.61e-05	0.00041	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—breast cancer	4.6e-05	0.00041	CcSEcCtD
L-Carnitine—Anxiety—Capecitabine—breast cancer	4.6e-05	0.000409	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—breast cancer	4.56e-05	0.000406	CcSEcCtD
L-Carnitine—Pruritus—Gemcitabine—breast cancer	4.56e-05	0.000405	CcSEcCtD
L-Carnitine—Nausea—Thiotepa—breast cancer	4.55e-05	0.000405	CcSEcCtD
L-Carnitine—Infection—Docetaxel—breast cancer	4.54e-05	0.000404	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—breast cancer	4.54e-05	0.000404	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—breast cancer	4.53e-05	0.000404	CcSEcCtD
L-Carnitine—Diarrhoea—Irinotecan—breast cancer	4.52e-05	0.000403	CcSEcCtD
L-Carnitine—Diarrhoea—Mitoxantrone—breast cancer	4.52e-05	0.000403	CcSEcCtD
L-Carnitine—Pruritus—Fluorouracil—breast cancer	4.48e-05	0.000399	CcSEcCtD
L-Carnitine—Tachycardia—Docetaxel—breast cancer	4.46e-05	0.000397	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Paclitaxel—breast cancer	4.41e-05	0.000392	CcSEcCtD
L-Carnitine—Diarrhoea—Gemcitabine—breast cancer	4.41e-05	0.000392	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—breast cancer	4.4e-05	0.000391	CcSEcCtD
L-Carnitine—Infection—Capecitabine—breast cancer	4.4e-05	0.000391	CcSEcCtD
L-Carnitine—Dizziness—Irinotecan—breast cancer	4.37e-05	0.000389	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—breast cancer	4.36e-05	0.000388	CcSEcCtD
L-Carnitine—Anorexia—Docetaxel—breast cancer	4.36e-05	0.000388	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—breast cancer	4.35e-05	0.000387	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—breast cancer	4.35e-05	0.000387	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—breast cancer	4.34e-05	0.000386	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—breast cancer	4.33e-05	0.000386	CcSEcCtD
L-Carnitine—Diarrhoea—Fluorouracil—breast cancer	4.33e-05	0.000386	CcSEcCtD
L-Carnitine—Tachycardia—Capecitabine—breast cancer	4.32e-05	0.000384	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—breast cancer	4.31e-05	0.000383	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—breast cancer	4.27e-05	0.00038	CcSEcCtD
L-Carnitine—Hypotension—Docetaxel—breast cancer	4.27e-05	0.00038	CcSEcCtD
L-Carnitine—Body temperature increased—Paclitaxel—breast cancer	4.26e-05	0.000379	CcSEcCtD
L-Carnitine—Abdominal pain—Paclitaxel—breast cancer	4.26e-05	0.000379	CcSEcCtD
L-Carnitine—Anorexia—Capecitabine—breast cancer	4.22e-05	0.000375	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—breast cancer	4.21e-05	0.000374	CcSEcCtD
L-Carnitine—Vomiting—Mitoxantrone—breast cancer	4.2e-05	0.000374	CcSEcCtD
L-Carnitine—Vomiting—Irinotecan—breast cancer	4.2e-05	0.000374	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—breast cancer	4.2e-05	0.000373	CcSEcCtD
L-Carnitine—Dizziness—Fluorouracil—breast cancer	4.19e-05	0.000373	CcSEcCtD
L-Carnitine—Rash—Irinotecan—breast cancer	4.17e-05	0.000371	CcSEcCtD
L-Carnitine—Rash—Mitoxantrone—breast cancer	4.17e-05	0.000371	CcSEcCtD
L-Carnitine—Dermatitis—Mitoxantrone—breast cancer	4.16e-05	0.000371	CcSEcCtD
L-Carnitine—Dermatitis—Irinotecan—breast cancer	4.16e-05	0.000371	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.16e-05	0.000371	CcSEcCtD
L-Carnitine—Headache—Mitoxantrone—breast cancer	4.14e-05	0.000369	CcSEcCtD
L-Carnitine—Headache—Irinotecan—breast cancer	4.14e-05	0.000369	CcSEcCtD
L-Carnitine—Hypotension—Capecitabine—breast cancer	4.13e-05	0.000368	CcSEcCtD
L-Carnitine—Insomnia—Docetaxel—breast cancer	4.13e-05	0.000368	CcSEcCtD
L-Carnitine—Paraesthesia—Docetaxel—breast cancer	4.1e-05	0.000365	CcSEcCtD
L-Carnitine—Vomiting—Gemcitabine—breast cancer	4.09e-05	0.000364	CcSEcCtD
L-Carnitine—Dyspnoea—Docetaxel—breast cancer	4.07e-05	0.000363	CcSEcCtD
L-Carnitine—Rash—Gemcitabine—breast cancer	4.06e-05	0.000361	CcSEcCtD
L-Carnitine—Dermatitis—Gemcitabine—breast cancer	4.06e-05	0.000361	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—breast cancer	4.05e-05	0.000361	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—breast cancer	4.03e-05	0.000359	CcSEcCtD
L-Carnitine—Headache—Gemcitabine—breast cancer	4.03e-05	0.000359	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.03e-05	0.000359	CcSEcCtD
L-Carnitine—Vomiting—Fluorouracil—breast cancer	4.03e-05	0.000358	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—breast cancer	4.02e-05	0.000358	CcSEcCtD
L-Carnitine—Dyspepsia—Docetaxel—breast cancer	4.02e-05	0.000358	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—breast cancer	4.01e-05	0.000357	CcSEcCtD
L-Carnitine—Insomnia—Capecitabine—breast cancer	4e-05	0.000356	CcSEcCtD
L-Carnitine—Rash—Fluorouracil—breast cancer	3.99e-05	0.000355	CcSEcCtD
L-Carnitine—Dermatitis—Fluorouracil—breast cancer	3.99e-05	0.000355	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—breast cancer	3.98e-05	0.000355	CcSEcCtD
L-Carnitine—Paraesthesia—Capecitabine—breast cancer	3.97e-05	0.000354	CcSEcCtD
L-Carnitine—Decreased appetite—Docetaxel—breast cancer	3.97e-05	0.000354	CcSEcCtD
L-Carnitine—Hypersensitivity—Paclitaxel—breast cancer	3.97e-05	0.000354	CcSEcCtD
L-Carnitine—Headache—Fluorouracil—breast cancer	3.97e-05	0.000353	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—breast cancer	3.95e-05	0.000352	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—breast cancer	3.95e-05	0.000352	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Docetaxel—breast cancer	3.95e-05	0.000351	CcSEcCtD
L-Carnitine—Dyspnoea—Capecitabine—breast cancer	3.94e-05	0.000351	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—breast cancer	3.94e-05	0.00035	CcSEcCtD
L-Carnitine—Nausea—Mitoxantrone—breast cancer	3.93e-05	0.000349	CcSEcCtD
L-Carnitine—Nausea—Irinotecan—breast cancer	3.93e-05	0.000349	CcSEcCtD
L-Carnitine—Constipation—Docetaxel—breast cancer	3.91e-05	0.000348	CcSEcCtD
L-Carnitine—Pain—Docetaxel—breast cancer	3.91e-05	0.000348	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—breast cancer	3.9e-05	0.000347	CcSEcCtD
L-Carnitine—Dyspepsia—Capecitabine—breast cancer	3.89e-05	0.000347	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—breast cancer	3.88e-05	0.000345	CcSEcCtD
L-Carnitine—Asthenia—Paclitaxel—breast cancer	3.87e-05	0.000344	CcSEcCtD
L-Carnitine—Decreased appetite—Capecitabine—breast cancer	3.85e-05	0.000342	CcSEcCtD
L-Carnitine—Nausea—Gemcitabine—breast cancer	3.82e-05	0.00034	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Capecitabine—breast cancer	3.82e-05	0.00034	CcSEcCtD
L-Carnitine—Pruritus—Paclitaxel—breast cancer	3.81e-05	0.000339	CcSEcCtD
L-Carnitine—Pain—Capecitabine—breast cancer	3.78e-05	0.000337	CcSEcCtD
L-Carnitine—Constipation—Capecitabine—breast cancer	3.78e-05	0.000337	CcSEcCtD
L-Carnitine—Nausea—Fluorouracil—breast cancer	3.76e-05	0.000335	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—breast cancer	3.75e-05	0.000334	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Docetaxel—breast cancer	3.74e-05	0.000333	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—breast cancer	3.73e-05	0.000332	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—breast cancer	3.7e-05	0.000329	CcSEcCtD
L-Carnitine—Diarrhoea—Paclitaxel—breast cancer	3.69e-05	0.000328	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—breast cancer	3.65e-05	0.000325	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—breast cancer	3.64e-05	0.000324	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—breast cancer	3.63e-05	0.000323	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—breast cancer	3.63e-05	0.000323	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Capecitabine—breast cancer	3.62e-05	0.000322	CcSEcCtD
L-Carnitine—Abdominal pain—Docetaxel—breast cancer	3.61e-05	0.000322	CcSEcCtD
L-Carnitine—Body temperature increased—Docetaxel—breast cancer	3.61e-05	0.000322	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—breast cancer	3.59e-05	0.000319	CcSEcCtD
L-Carnitine—Dizziness—Paclitaxel—breast cancer	3.57e-05	0.000317	CcSEcCtD
L-Carnitine—Cough—Methotrexate—breast cancer	3.52e-05	0.000313	CcSEcCtD
L-Carnitine—Body temperature increased—Capecitabine—breast cancer	3.5e-05	0.000311	CcSEcCtD
L-Carnitine—Abdominal pain—Capecitabine—breast cancer	3.5e-05	0.000311	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—breast cancer	3.5e-05	0.000311	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—breast cancer	3.49e-05	0.000311	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—breast cancer	3.44e-05	0.000306	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—breast cancer	3.44e-05	0.000306	CcSEcCtD
L-Carnitine—Vomiting—Paclitaxel—breast cancer	3.43e-05	0.000305	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—breast cancer	3.42e-05	0.000305	CcSEcCtD
L-Carnitine—Rash—Paclitaxel—breast cancer	3.4e-05	0.000303	CcSEcCtD
L-Carnitine—Dermatitis—Paclitaxel—breast cancer	3.4e-05	0.000302	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—breast cancer	3.39e-05	0.000302	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—breast cancer	3.38e-05	0.000301	CcSEcCtD
L-Carnitine—Headache—Paclitaxel—breast cancer	3.38e-05	0.000301	CcSEcCtD
L-Carnitine—Hypersensitivity—Docetaxel—breast cancer	3.37e-05	0.0003	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—breast cancer	3.36e-05	0.000299	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—breast cancer	3.34e-05	0.000297	CcSEcCtD
L-Carnitine—Cough—Epirubicin—breast cancer	3.3e-05	0.000293	CcSEcCtD
L-Carnitine—Asthenia—Docetaxel—breast cancer	3.28e-05	0.000292	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—breast cancer	3.27e-05	0.000291	CcSEcCtD
L-Carnitine—Infection—Methotrexate—breast cancer	3.27e-05	0.000291	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—breast cancer	3.26e-05	0.00029	CcSEcCtD
L-Carnitine—Hypersensitivity—Capecitabine—breast cancer	3.26e-05	0.00029	CcSEcCtD
L-Carnitine—Pruritus—Docetaxel—breast cancer	3.23e-05	0.000288	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—breast cancer	3.23e-05	0.000287	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—breast cancer	3.22e-05	0.000286	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—breast cancer	3.22e-05	0.000286	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—breast cancer	3.2e-05	0.000285	CcSEcCtD
L-Carnitine—Nausea—Paclitaxel—breast cancer	3.2e-05	0.000285	CcSEcCtD
L-Carnitine—Asthenia—Capecitabine—breast cancer	3.17e-05	0.000283	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—breast cancer	3.14e-05	0.000279	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—breast cancer	3.14e-05	0.000279	CcSEcCtD
L-Carnitine—Pruritus—Capecitabine—breast cancer	3.13e-05	0.000279	CcSEcCtD
L-Carnitine—Diarrhoea—Docetaxel—breast cancer	3.13e-05	0.000278	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—breast cancer	3.09e-05	0.000275	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—breast cancer	3.08e-05	0.000274	CcSEcCtD
L-Carnitine—Infection—Epirubicin—breast cancer	3.06e-05	0.000273	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—breast cancer	3.05e-05	0.000271	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—breast cancer	3.03e-05	0.000269	CcSEcCtD
L-Carnitine—Diarrhoea—Capecitabine—breast cancer	3.03e-05	0.000269	CcSEcCtD
L-Carnitine—Dizziness—Docetaxel—breast cancer	3.02e-05	0.000269	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—breast cancer	3.02e-05	0.000269	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—breast cancer	3.01e-05	0.000268	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—breast cancer	3e-05	0.000267	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—breast cancer	2.98e-05	0.000265	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—breast cancer	2.97e-05	0.000265	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—breast cancer	2.97e-05	0.000265	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—breast cancer	2.96e-05	0.000264	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—breast cancer	2.96e-05	0.000263	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—breast cancer	2.94e-05	0.000262	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—breast cancer	2.94e-05	0.000261	CcSEcCtD
L-Carnitine—Dizziness—Capecitabine—breast cancer	2.93e-05	0.00026	CcSEcCtD
L-Carnitine—Vomiting—Docetaxel—breast cancer	2.91e-05	0.000259	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—breast cancer	2.9e-05	0.000258	CcSEcCtD
L-Carnitine—Rash—Docetaxel—breast cancer	2.88e-05	0.000256	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—breast cancer	2.88e-05	0.000256	CcSEcCtD
L-Carnitine—Dermatitis—Docetaxel—breast cancer	2.88e-05	0.000256	CcSEcCtD
L-Carnitine—Decreased appetite—Methotrexate—breast cancer	2.86e-05	0.000255	CcSEcCtD
L-Carnitine—Headache—Docetaxel—breast cancer	2.86e-05	0.000255	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—breast cancer	2.84e-05	0.000253	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—breast cancer	2.83e-05	0.000252	CcSEcCtD
L-Carnitine—Pain—Methotrexate—breast cancer	2.82e-05	0.000251	CcSEcCtD
L-Carnitine—Vomiting—Capecitabine—breast cancer	2.81e-05	0.00025	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.81e-05	0.00025	CcSEcCtD
L-Carnitine—Rash—Capecitabine—breast cancer	2.79e-05	0.000248	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—breast cancer	2.79e-05	0.000248	CcSEcCtD
L-Carnitine—Dermatitis—Capecitabine—breast cancer	2.79e-05	0.000248	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—breast cancer	2.78e-05	0.000248	CcSEcCtD
L-Carnitine—Headache—Capecitabine—breast cancer	2.77e-05	0.000247	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—breast cancer	2.77e-05	0.000246	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—breast cancer	2.75e-05	0.000245	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—breast cancer	2.72e-05	0.000242	CcSEcCtD
L-Carnitine—Nausea—Docetaxel—breast cancer	2.71e-05	0.000242	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—breast cancer	2.71e-05	0.000241	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—breast cancer	2.69e-05	0.00024	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—breast cancer	2.68e-05	0.000238	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—breast cancer	2.66e-05	0.000237	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—breast cancer	2.66e-05	0.000237	CcSEcCtD
L-Carnitine—Pain—Epirubicin—breast cancer	2.64e-05	0.000235	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—breast cancer	2.64e-05	0.000235	CcSEcCtD
L-Carnitine—Nausea—Capecitabine—breast cancer	2.63e-05	0.000234	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—breast cancer	2.6e-05	0.000232	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—breast cancer	2.6e-05	0.000232	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.6e-05	0.000231	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—breast cancer	2.58e-05	0.00023	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—breast cancer	2.56e-05	0.000228	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—breast cancer	2.54e-05	0.000226	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—breast cancer	2.52e-05	0.000224	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—breast cancer	2.51e-05	0.000223	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—breast cancer	2.48e-05	0.000221	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.46e-05	0.000219	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—breast cancer	2.44e-05	0.000217	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—breast cancer	2.44e-05	0.000217	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—breast cancer	2.44e-05	0.000217	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—breast cancer	2.44e-05	0.000217	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—breast cancer	2.43e-05	0.000216	CcSEcCtD
L-Carnitine—Asthenia—Methotrexate—breast cancer	2.36e-05	0.00021	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Doxorubicin—breast cancer	2.33e-05	0.000208	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—breast cancer	2.33e-05	0.000207	CcSEcCtD
L-Carnitine—Hypersensitivity—Epirubicin—breast cancer	2.27e-05	0.000202	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—breast cancer	2.25e-05	0.000201	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—breast cancer	2.25e-05	0.000201	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—breast cancer	2.25e-05	0.000201	CcSEcCtD
L-Carnitine—Asthenia—Epirubicin—breast cancer	2.21e-05	0.000197	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—breast cancer	2.18e-05	0.000194	CcSEcCtD
L-Carnitine—Dizziness—Methotrexate—breast cancer	2.18e-05	0.000194	CcSEcCtD
L-Carnitine—Diarrhoea—Epirubicin—breast cancer	2.11e-05	0.000188	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—breast cancer	2.1e-05	0.000187	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—breast cancer	2.09e-05	0.000186	CcSEcCtD
L-Carnitine—Rash—Methotrexate—breast cancer	2.08e-05	0.000185	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—breast cancer	2.07e-05	0.000185	CcSEcCtD
L-Carnitine—Headache—Methotrexate—breast cancer	2.06e-05	0.000184	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—breast cancer	2.05e-05	0.000182	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—breast cancer	2.04e-05	0.000181	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—breast cancer	2.02e-05	0.00018	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—breast cancer	1.96e-05	0.000174	CcSEcCtD
L-Carnitine—Nausea—Methotrexate—breast cancer	1.96e-05	0.000174	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—breast cancer	1.95e-05	0.000174	CcSEcCtD
L-Carnitine—Rash—Epirubicin—breast cancer	1.94e-05	0.000173	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—breast cancer	1.94e-05	0.000173	CcSEcCtD
L-Carnitine—Headache—Epirubicin—breast cancer	1.93e-05	0.000172	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—breast cancer	1.89e-05	0.000168	CcSEcCtD
L-Carnitine—Nausea—Epirubicin—breast cancer	1.83e-05	0.000163	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—breast cancer	1.81e-05	0.000161	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—breast cancer	1.8e-05	0.00016	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—breast cancer	1.8e-05	0.00016	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—breast cancer	1.79e-05	0.000159	CcSEcCtD
L-Carnitine—Nausea—Doxorubicin—breast cancer	1.69e-05	0.000151	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—SLC5A5—breast cancer	1.02e-05	0.000107	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NAT2—breast cancer	1.02e-05	0.000106	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.01e-05	0.000105	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	1e-05	0.000104	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NQO1—breast cancer	9.87e-06	0.000103	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A1—breast cancer	9.87e-06	0.000103	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—breast cancer	9.8e-06	0.000102	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	9.79e-06	0.000102	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	9.78e-06	0.000102	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COX11—breast cancer	9.75e-06	0.000102	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.68e-06	0.000101	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.67e-06	0.000101	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—MTHFR—breast cancer	9.65e-06	0.000101	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—breast cancer	9.64e-06	0.0001	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—breast cancer	9.64e-06	0.0001	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP3A4—breast cancer	9.63e-06	0.0001	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	9.59e-06	0.0001	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.58e-06	9.99e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—breast cancer	9.55e-06	9.96e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—breast cancer	9.55e-06	9.96e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	9.54e-06	9.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—breast cancer	9.49e-06	9.89e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1B1—breast cancer	9.47e-06	9.87e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	9.41e-06	9.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	9.3e-06	9.7e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCG2—breast cancer	9.3e-06	9.69e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HSP90AA1—breast cancer	9.28e-06	9.68e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOA1—breast cancer	9.03e-06	9.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CDA—breast cancer	8.92e-06	9.3e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SHMT1—breast cancer	8.92e-06	9.3e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—STK11—breast cancer	8.9e-06	9.28e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP19A1—breast cancer	8.9e-06	9.28e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MED12—breast cancer	8.9e-06	9.28e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—DPYD—breast cancer	8.9e-06	9.28e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAV1—breast cancer	8.9e-06	9.28e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	8.85e-06	9.23e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	8.8e-06	9.18e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	8.8e-06	9.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALDOA—breast cancer	8.76e-06	9.13e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	8.72e-06	9.09e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	8.63e-06	8.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A5—breast cancer	8.58e-06	8.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA3—breast cancer	8.51e-06	8.87e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.5e-06	8.86e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	8.45e-06	8.81e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A2—breast cancer	8.45e-06	8.8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	8.39e-06	8.75e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.35e-06	8.71e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—breast cancer	8.33e-06	8.68e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—breast cancer	8.33e-06	8.68e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APRT—breast cancer	8.29e-06	8.64e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TFRC—breast cancer	8.29e-06	8.64e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—COMT—breast cancer	8.27e-06	8.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCG2—breast cancer	8.27e-06	8.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CPT1A—breast cancer	8.27e-06	8.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTR—breast cancer	8.27e-06	8.63e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—breast cancer	8.24e-06	8.58e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—breast cancer	8.14e-06	8.48e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HMOX1—breast cancer	8.12e-06	8.47e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HPGDS—breast cancer	8.11e-06	8.46e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—breast cancer	8.11e-06	8.45e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ITPR1—breast cancer	8.1e-06	8.45e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	8.1e-06	8.45e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HBA1—breast cancer	8.06e-06	8.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NCOA2—breast cancer	7.98e-06	8.32e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	7.96e-06	8.3e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ACHE—breast cancer	7.87e-06	8.2e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTT1—breast cancer	7.87e-06	8.2e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—breast cancer	7.8e-06	8.13e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ESRRA—breast cancer	7.79e-06	8.12e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ANGPTL4—breast cancer	7.79e-06	8.12e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMS—breast cancer	7.66e-06	7.98e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	7.64e-06	7.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.61e-06	7.93e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PLA2G4A—breast cancer	7.57e-06	7.89e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NCOR1—breast cancer	7.57e-06	7.89e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—breast cancer	7.57e-06	7.89e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP17A1—breast cancer	7.45e-06	7.77e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	7.41e-06	7.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HADHB—breast cancer	7.39e-06	7.7e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPI—breast cancer	7.39e-06	7.7e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS1—breast cancer	7.37e-06	7.69e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO1—breast cancer	7.37e-06	7.69e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.35e-06	7.66e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPX1—breast cancer	7.25e-06	7.55e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2D6—breast cancer	7.23e-06	7.54e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—breast cancer	7.17e-06	7.48e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—breast cancer	7.14e-06	7.45e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—breast cancer	7.13e-06	7.43e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ERCC2—breast cancer	7.12e-06	7.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA2—breast cancer	7.1e-06	7.4e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	7.07e-06	7.37e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDH1A1—breast cancer	7.05e-06	7.35e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDH7A1—breast cancer	7.05e-06	7.35e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—breast cancer	7.04e-06	7.33e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—breast cancer	7.03e-06	7.33e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	6.97e-06	7.26e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—breast cancer	6.91e-06	7.2e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—FASN—breast cancer	6.89e-06	7.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCHE—breast cancer	6.86e-06	7.15e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A5—breast cancer	6.77e-06	7.06e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PHGDH—breast cancer	6.76e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ADSL—breast cancer	6.76e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NME1—breast cancer	6.76e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FHL2—breast cancer	6.76e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UMPS—breast cancer	6.76e-06	7.04e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NOS3—breast cancer	6.73e-06	7.02e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—NCOA1—breast cancer	6.72e-06	7.01e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—MTHFR—breast cancer	6.69e-06	6.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BRIP1—breast cancer	6.63e-06	6.91e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPSE—breast cancer	6.63e-06	6.91e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—LDHB—breast cancer	6.63e-06	6.91e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—PLG—breast cancer	6.55e-06	6.83e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A1—breast cancer	6.54e-06	6.82e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NQO1—breast cancer	6.54e-06	6.82e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP3A4—breast cancer	6.38e-06	6.65e-05	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—RAF1—breast cancer	6.36e-06	6.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA3—breast cancer	6.28e-06	6.55e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMMR—breast cancer	6.28e-06	6.55e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCC1—breast cancer	6.28e-06	6.55e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1B1—breast cancer	6.27e-06	6.54e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—breast cancer	6.21e-06	6.48e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAV1—breast cancer	6.17e-06	6.43e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—breast cancer	6.16e-06	6.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HSP90AA1—breast cancer	6.15e-06	6.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARGC1B—breast cancer	6.08e-06	6.34e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—breast cancer	6.05e-06	6.3e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOA1—breast cancer	5.98e-06	6.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.92e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.92e-06	6.18e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—STK11—breast cancer	5.9e-06	6.15e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP19A1—breast cancer	5.9e-06	6.15e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.89e-06	6.14e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—breast cancer	5.88e-06	6.13e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—breast cancer	5.88e-06	6.13e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—breast cancer	5.8e-06	6.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CA9—breast cancer	5.75e-06	5.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA4—breast cancer	5.75e-06	5.99e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.67e-06	5.91e-05	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—breast cancer	5.65e-06	5.89e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—breast cancer	5.62e-06	5.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.62e-06	5.85e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA2—breast cancer	5.6e-06	5.84e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX2—breast cancer	5.6e-06	5.84e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX4—breast cancer	5.53e-06	5.77e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SULT1A1—breast cancer	5.53e-06	5.77e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—COMT—breast cancer	5.48e-06	5.71e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—breast cancer	5.46e-06	5.69e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH1—breast cancer	5.4e-06	5.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTA1—breast cancer	5.4e-06	5.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HMOX1—breast cancer	5.38e-06	5.61e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—breast cancer	5.37e-06	5.6e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ITPR1—breast cancer	5.37e-06	5.6e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAT2—breast cancer	5.34e-06	5.57e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	5.29e-06	5.51e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—breast cancer	5.16e-06	5.38e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMS—breast cancer	5.07e-06	5.29e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NCOR1—breast cancer	5.01e-06	5.23e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLA2G4A—breast cancer	5.01e-06	5.23e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—breast cancer	5.01e-06	5.23e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—breast cancer	4.94e-06	5.15e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—breast cancer	4.88e-06	5.08e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.83e-06	5.03e-05	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—breast cancer	4.8e-06	5e-05	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—breast cancer	4.8e-06	5e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPX1—breast cancer	4.8e-06	5e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	4.78e-06	4.98e-05	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	4.78e-06	4.98e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—breast cancer	4.75e-06	4.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ERCC2—breast cancer	4.71e-06	4.91e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MED12—breast cancer	4.68e-06	4.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DPYD—breast cancer	4.68e-06	4.88e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NOS3—breast cancer	4.66e-06	4.86e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALDOA—breast cancer	4.61e-06	4.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA3—breast cancer	4.48e-06	4.67e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A2—breast cancer	4.45e-06	4.63e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—MTHFR—breast cancer	4.43e-06	4.62e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.4e-06	4.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCG2—breast cancer	4.35e-06	4.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTR—breast cancer	4.35e-06	4.54e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CPT1A—breast cancer	4.35e-06	4.54e-05	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	4.32e-06	4.51e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—breast cancer	4.31e-06	4.49e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPGDS—breast cancer	4.27e-06	4.45e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—breast cancer	4.27e-06	4.45e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HBA1—breast cancer	4.24e-06	4.42e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ACHE—breast cancer	4.14e-06	4.32e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTT1—breast cancer	4.14e-06	4.32e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAV1—breast cancer	4.09e-06	4.26e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP17A1—breast cancer	3.92e-06	4.09e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO1—breast cancer	3.88e-06	4.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS1—breast cancer	3.88e-06	4.05e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.87e-06	4.03e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.82e-06	3.98e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2D6—breast cancer	3.81e-06	3.97e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—breast cancer	3.79e-06	3.95e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA2—breast cancer	3.74e-06	3.89e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—breast cancer	3.72e-06	3.88e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—breast cancer	3.72e-06	3.88e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—breast cancer	3.63e-06	3.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FASN—breast cancer	3.62e-06	3.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCHE—breast cancer	3.61e-06	3.76e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A5—breast cancer	3.56e-06	3.72e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A1—breast cancer	3.44e-06	3.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NQO1—breast cancer	3.44e-06	3.59e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.37e-06	3.51e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP3A4—breast cancer	3.36e-06	3.5e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.34e-06	3.48e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1B1—breast cancer	3.3e-06	3.44e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—RAF1—breast cancer	3.28e-06	3.42e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—breast cancer	3.27e-06	3.41e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSP90AA1—breast cancer	3.24e-06	3.37e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—breast cancer	3.23e-06	3.37e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOA1—breast cancer	3.15e-06	3.28e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STK11—breast cancer	3.1e-06	3.23e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP19A1—breast cancer	3.1e-06	3.23e-05	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—breast cancer	3.09e-06	3.22e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NOS3—breast cancer	3.09e-06	3.22e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.91e-06	3.04e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COMT—breast cancer	2.88e-06	3.01e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—breast cancer	2.87e-06	2.99e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—breast cancer	2.85e-06	2.97e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HMOX1—breast cancer	2.83e-06	2.95e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—breast cancer	2.83e-06	2.95e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ITPR1—breast cancer	2.83e-06	2.94e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—breast cancer	2.72e-06	2.83e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMS—breast cancer	2.67e-06	2.78e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NCOR1—breast cancer	2.64e-06	2.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLA2G4A—breast cancer	2.64e-06	2.75e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—breast cancer	2.64e-06	2.75e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—breast cancer	2.62e-06	2.74e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX1—breast cancer	2.53e-06	2.63e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—breast cancer	2.5e-06	2.61e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ERCC2—breast cancer	2.48e-06	2.59e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—breast cancer	2.46e-06	2.57e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—MTHFR—breast cancer	2.33e-06	2.43e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAV1—breast cancer	2.15e-06	2.24e-05	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—breast cancer	2.14e-06	2.24e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.05e-06	2.14e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.96e-06	2.04e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—breast cancer	1.74e-06	1.81e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.72e-06	1.8e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—breast cancer	1.7e-06	1.77e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NOS3—breast cancer	1.63e-06	1.7e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.5e-06	1.56e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—breast cancer	1.49e-06	1.55e-05	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—breast cancer	1.42e-06	1.48e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—breast cancer	1.3e-06	1.35e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—breast cancer	9.15e-07	9.54e-06	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—breast cancer	7.48e-07	7.79e-06	CbGpPWpGaD
